Electrostatic-mediated enhancement of protein antigen immunogenicity using charged TLR2-targeting lipopeptides

Brendon Y. Chua, David Pejoski, Stephen J. Turner, Weiguang Zeng, David C. Jackson

Research output: Contribution to journalArticleResearchpeer-review

Abstract

The low immunogenicities exhibited by most soluble proteins are in general due to the absence of any molecular signatures that are recognized by the immune system as dangerous. We show here that electrostatic binding of synthetic branched cationic or anionic lipopeptides that contain the TLR2 agonist Pam2Cys can markedly enhance protein immunogenicity. High protein-specific antibody titres in animals were achieved by vaccination with formulations containing lipopeptide and protein of opposite charge. This response was not totally dependent on electrostatic binding because vaccination with similarly charged constituents also resulted in the induction of strong, albeit lower, antibody titres. The induction of CD8+ T cell-mediated responses, however, was achieved only by vaccination with formulations containing lipopeptide and protein of opposite but not similar charge. These responses also correlated with the ability of the electrostatically associated lipopeptide to facilitate dendritic cell uptake of protein antigen and trafficking into the draining lymph node. Vaccination subsequently resulted in faster viral clearance upon pulmonary infectious challenge with a chimeric influenza virus. The improvement in protein antigen immunogenicity obtained by mixing with lipopeptide led to a 99% reduction in lung viral titres and correlates with the presence of substantial numbers of antigen-specific CD8+ T cells in lung bronchoalveolar washes.

Original languageEnglish
Pages (from-to)80-84
Number of pages5
JournalProcedia in Vaccinology
Volume6
DOIs
Publication statusPublished - 2012
Externally publishedYes

Keywords

  • Antibody
  • CD8+ T cell responses
  • Influenza virus
  • Lipopeptide
  • Protein immunogenicity
  • TLR2

Cite this

Chua, Brendon Y. ; Pejoski, David ; Turner, Stephen J. ; Zeng, Weiguang ; Jackson, David C. / Electrostatic-mediated enhancement of protein antigen immunogenicity using charged TLR2-targeting lipopeptides. In: Procedia in Vaccinology. 2012 ; Vol. 6. pp. 80-84.
@article{7d61e4c7503b40cba56986709a6543b4,
title = "Electrostatic-mediated enhancement of protein antigen immunogenicity using charged TLR2-targeting lipopeptides",
abstract = "The low immunogenicities exhibited by most soluble proteins are in general due to the absence of any molecular signatures that are recognized by the immune system as dangerous. We show here that electrostatic binding of synthetic branched cationic or anionic lipopeptides that contain the TLR2 agonist Pam2Cys can markedly enhance protein immunogenicity. High protein-specific antibody titres in animals were achieved by vaccination with formulations containing lipopeptide and protein of opposite charge. This response was not totally dependent on electrostatic binding because vaccination with similarly charged constituents also resulted in the induction of strong, albeit lower, antibody titres. The induction of CD8+ T cell-mediated responses, however, was achieved only by vaccination with formulations containing lipopeptide and protein of opposite but not similar charge. These responses also correlated with the ability of the electrostatically associated lipopeptide to facilitate dendritic cell uptake of protein antigen and trafficking into the draining lymph node. Vaccination subsequently resulted in faster viral clearance upon pulmonary infectious challenge with a chimeric influenza virus. The improvement in protein antigen immunogenicity obtained by mixing with lipopeptide led to a 99{\%} reduction in lung viral titres and correlates with the presence of substantial numbers of antigen-specific CD8+ T cells in lung bronchoalveolar washes.",
keywords = "Antibody, CD8+ T cell responses, Influenza virus, Lipopeptide, Protein immunogenicity, TLR2",
author = "Chua, {Brendon Y.} and David Pejoski and Turner, {Stephen J.} and Weiguang Zeng and Jackson, {David C.}",
year = "2012",
doi = "10.1016/j.provac.2012.04.011",
language = "English",
volume = "6",
pages = "80--84",
journal = "Procedia in Vaccinology",
issn = "1877-282X",
publisher = "Elsevier",

}

Electrostatic-mediated enhancement of protein antigen immunogenicity using charged TLR2-targeting lipopeptides. / Chua, Brendon Y.; Pejoski, David; Turner, Stephen J.; Zeng, Weiguang; Jackson, David C.

In: Procedia in Vaccinology, Vol. 6, 2012, p. 80-84.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Electrostatic-mediated enhancement of protein antigen immunogenicity using charged TLR2-targeting lipopeptides

AU - Chua, Brendon Y.

AU - Pejoski, David

AU - Turner, Stephen J.

AU - Zeng, Weiguang

AU - Jackson, David C.

PY - 2012

Y1 - 2012

N2 - The low immunogenicities exhibited by most soluble proteins are in general due to the absence of any molecular signatures that are recognized by the immune system as dangerous. We show here that electrostatic binding of synthetic branched cationic or anionic lipopeptides that contain the TLR2 agonist Pam2Cys can markedly enhance protein immunogenicity. High protein-specific antibody titres in animals were achieved by vaccination with formulations containing lipopeptide and protein of opposite charge. This response was not totally dependent on electrostatic binding because vaccination with similarly charged constituents also resulted in the induction of strong, albeit lower, antibody titres. The induction of CD8+ T cell-mediated responses, however, was achieved only by vaccination with formulations containing lipopeptide and protein of opposite but not similar charge. These responses also correlated with the ability of the electrostatically associated lipopeptide to facilitate dendritic cell uptake of protein antigen and trafficking into the draining lymph node. Vaccination subsequently resulted in faster viral clearance upon pulmonary infectious challenge with a chimeric influenza virus. The improvement in protein antigen immunogenicity obtained by mixing with lipopeptide led to a 99% reduction in lung viral titres and correlates with the presence of substantial numbers of antigen-specific CD8+ T cells in lung bronchoalveolar washes.

AB - The low immunogenicities exhibited by most soluble proteins are in general due to the absence of any molecular signatures that are recognized by the immune system as dangerous. We show here that electrostatic binding of synthetic branched cationic or anionic lipopeptides that contain the TLR2 agonist Pam2Cys can markedly enhance protein immunogenicity. High protein-specific antibody titres in animals were achieved by vaccination with formulations containing lipopeptide and protein of opposite charge. This response was not totally dependent on electrostatic binding because vaccination with similarly charged constituents also resulted in the induction of strong, albeit lower, antibody titres. The induction of CD8+ T cell-mediated responses, however, was achieved only by vaccination with formulations containing lipopeptide and protein of opposite but not similar charge. These responses also correlated with the ability of the electrostatically associated lipopeptide to facilitate dendritic cell uptake of protein antigen and trafficking into the draining lymph node. Vaccination subsequently resulted in faster viral clearance upon pulmonary infectious challenge with a chimeric influenza virus. The improvement in protein antigen immunogenicity obtained by mixing with lipopeptide led to a 99% reduction in lung viral titres and correlates with the presence of substantial numbers of antigen-specific CD8+ T cells in lung bronchoalveolar washes.

KW - Antibody

KW - CD8+ T cell responses

KW - Influenza virus

KW - Lipopeptide

KW - Protein immunogenicity

KW - TLR2

UR - http://www.scopus.com/inward/record.url?scp=84860431730&partnerID=8YFLogxK

U2 - 10.1016/j.provac.2012.04.011

DO - 10.1016/j.provac.2012.04.011

M3 - Article

VL - 6

SP - 80

EP - 84

JO - Procedia in Vaccinology

JF - Procedia in Vaccinology

SN - 1877-282X

ER -